Toll-like receptor modulators: a patent review (2006-2010).
about
The emerging role of Toll-like receptor 4 in myocardial inflammationMucins and toll-like receptors: kith and kin in infection and cancerTargeting Toll-like receptors with small molecule agentsIn silico approach to inhibition of signaling pathways of Toll-like receptors 2 and 4 by ST2LComparative analysis of species-specific ligand recognition in Toll-like receptor 8 signaling: a hypothesisAdjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.Evolutionary, structural and functional interplay of the IκB family members.Small molecule glutaminase inhibitors block glutamate release from stimulated microglia.Covalent modification of cell surfaces with TLR agonists improves & directs immune stimulation.Activating transcription factor 3 represses inflammatory responses by binding to the p65 subunit of NF-κBSystems Biological Approaches Reveal Non-additive Responses and Multiple Crosstalk Mechanisms between TLR and GPCR Signaling.Negative regulatory approaches to the attenuation of Toll-like receptor signaling.CpG-ODN Shapes Alum Adjuvant Activity Signaling via MyD88 and IL-10.Similar Structures but Different Roles - An Updated Perspective on TLR Structures.Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.Inflammation and adaptive immunity in Parkinson's disease.Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.siRNA and cancer immunotherapy.Toll-like receptor agonists: a patent review (2011 - 2013).Immunological and technical considerations in application of alginate-based microencapsulation systems.Interaction Between Helminths and Toll-Like Receptors: Possibilities and Potentials for Asthma Therapy.Recent progress in the development of Toll-like receptor (TLR) antagonists.Toll-like receptors: promising therapeutic targets for inflammatory diseases.Deciphering PDT-induced inflammatory responses using real-time FDG-PET in a mouse tumour model.Mesenchymal stem cells cannot affect mRNA expression of toll-like receptors in different tissues during sepsis.Synthetic nanovaccines for immunotherapy.Expression of Toll-Like Receptors in Chronic Histiocytic Intervillositis of the Placenta.Negative pressure wound therapy inhibits inflammation and upregulates activating transcription factor-3 and downregulates nuclear factor-κB in diabetic patients with foot ulcerations.AIPpred: Sequence-Based Prediction of Anti-inflammatory Peptides Using Random Forest.Efficient kinetic resolution of phenyl glycidyl ether by a novel epoxide hydrolase from Tsukamurella paurometabola.Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids.The adjuvant GLA-AF enhances human intradermal vaccine responses
P2860
Q26745749-336F0A5E-8419-4EEC-8A9B-72389513AF92Q26830597-BDEF9DEB-9C98-40D0-A319-EC17EA7ED5DBQ26992220-8D169DB8-EE74-4292-8678-A1D09289E9F9Q28476739-FD313E68-EF83-4151-A424-92239C55289DQ28477157-B3409931-05CC-48A5-B761-8EBFCB95CDC3Q33760871-C187A7A3-A29F-434F-911A-DF9F9C0EC848Q34571003-536AA0EE-C1D6-4960-A01D-7B694B7407E6Q35051773-6F01F96F-3DEA-4E2E-B79C-380792DF9D91Q35447388-9656F66F-E55C-4CD4-B628-A70E8639BF81Q36100176-AFB4CBA8-1D70-44AF-8D84-12C6E64573C6Q36381857-7C5BA751-4CCB-4608-AFE3-F1E4E5DE0F72Q36645845-C7FD4AC6-4A11-424D-81A2-3F5C599A6BAAQ37622083-9225272F-E042-471B-8C28-40DBB9508473Q37918392-58BE211B-DBBF-4CB0-A86A-A3AC9A144E47Q37943809-6F6C0E3A-AADE-4D96-8906-D0B31F000792Q37982378-D9FE92D3-F5E6-4D68-A543-46AEB8505368Q38039958-811C45D9-11AE-467B-AF2E-9F2C16D74202Q38050504-B0BB274F-72D8-446D-9EA7-3A20548FE140Q38181176-96D5002F-7505-49F2-812D-15FEFF9DF9A3Q38242227-E5F30232-408F-4C83-BFEC-B62858DA0FDEQ38819029-9046D15E-613B-4A29-B450-9DFC662A116EQ38823065-B363C97E-3EEF-4744-B406-69E3C102AF98Q38925152-B655AC52-BA37-4D92-A8BD-C3D6B6D0959AQ38972206-BC7C8782-AF4E-4F8A-BC87-77EC53F3F106Q40259205-B2500805-D207-4121-88DC-7828E442B543Q40280801-EB025FFA-1FE5-4211-A2AE-258D5A6D7F01Q47933664-1125C530-89D5-4F9D-9E59-9EC7BDE43F78Q51046849-653CFDC4-6419-4F1D-9C1B-4E348239BE9EQ52595216-535C6ABD-3670-404E-8999-1C16B0A43A5BQ53204799-DFEF6F73-25CC-4F61-9D58-9C923AFEDB3FQ55360178-ACE9BEA3-D595-40AA-A732-455575345DADQ57093670-040D64E3-E8A8-40A8-8157-D748269B84F3
P2860
Toll-like receptor modulators: a patent review (2006-2010).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Toll-like receptor modulators: a patent review (2006-2010).
@en
Toll-like receptor modulators: a patent review
@nl
type
label
Toll-like receptor modulators: a patent review (2006-2010).
@en
Toll-like receptor modulators: a patent review
@nl
prefLabel
Toll-like receptor modulators: a patent review (2006-2010).
@en
Toll-like receptor modulators: a patent review
@nl
P2093
P2860
P1476
Toll-like receptor modulators: a patent review (2006-2010).
@en
P2093
Balachandran Manavalan
Sang Geon Kim
Sangdun Choi
Shaherin Basith
P2860
P304
P356
10.1517/13543776.2011.569494
P407
P577
2011-03-15T00:00:00Z